292 related articles for article (PubMed ID: 32881007)
1. Are the steroids a blanket solution for COVID-19? A systematic review and meta-analysis.
Sarkar S; Khanna P; Soni KD
J Med Virol; 2021 Mar; 93(3):1538-1547. PubMed ID: 32881007
[TBL] [Abstract][Full Text] [Related]
2. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
3. Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: A systematic review and meta-analysis of randomised trials.
Caiazzo E; Rezig AOM; Bruzzese D; Ialenti A; Cicala C; Cleland JGF; Guzik TJ; Maffia P; Pellicori P
Pharmacol Res; 2022 Feb; 176():106053. PubMed ID: 34979235
[TBL] [Abstract][Full Text] [Related]
4. Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes: Systematic Review and Meta-analysis.
Cano EJ; Fonseca Fuentes X; Corsini Campioli C; O'Horo JC; Abu Saleh O; Odeyemi Y; Yadav H; Temesgen Z
Chest; 2021 Mar; 159(3):1019-1040. PubMed ID: 33129791
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of glucocorticoids to treat COVID-19: a rapid review and meta-analysis.
Lu S; Zhou Q; Huang L; Shi Q; Zhao S; Wang Z; Li W; Tang Y; Ma Y; Luo X; Fukuoka T; Ahn HS; Lee MS; Luo Z; Liu E; Chen Y; Zhou C; Peng D
Ann Transl Med; 2020 May; 8(10):627. PubMed ID: 32566564
[TBL] [Abstract][Full Text] [Related]
6. Convalescent plasma is a clutch at straws in COVID-19 management! A systematic review and meta-analysis.
Sarkar S; Soni KD; Khanna P
J Med Virol; 2021 Feb; 93(2):1111-1118. PubMed ID: 32776573
[TBL] [Abstract][Full Text] [Related]
7. Systemic corticosteroids for the treatment of COVID-19.
Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 Randomized Clinical Trial.
Cairns DM; Dulko D; Griffiths JK; Golan Y; Cohen T; Trinquart L; Price LL; Beaulac KR; Selker HP
JAMA Netw Open; 2022 Feb; 5(2):e2144942. PubMed ID: 35138402
[TBL] [Abstract][Full Text] [Related]
9. Perspectives on glucocorticoid treatment for COVID-19: a systematic review.
Cordeiro LP; Linhares EONN; Nogueira FGO; Moreira-Silva D; Medeiros-Lima DJM
Pharmacol Rep; 2021 Jun; 73(3):728-735. PubMed ID: 33666864
[TBL] [Abstract][Full Text] [Related]
10. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic anticoagulants for people hospitalised with COVID-19.
Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
[TBL] [Abstract][Full Text] [Related]
12. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
15. Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study.
Hao SR; Yan R; Zhang SY; Lian JS; Cai H; Zhang XL; Zheng L; Jia HY; Hu JH; Yu GD; Gu JQ; Ye CY; Jin CL; Lu YF; Xin JJ; Sheng JF; Yang YD
J Zhejiang Univ Sci B; 2020 Aug.; 21(8):628-636. PubMed ID: 32748578
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal viral shedding in children with SARS-CoV-2: a systematic review and meta-analysis.
Benvari S; Mahmoudi S; Mohammadi M
World J Pediatr; 2022 Sep; 18(9):582-588. PubMed ID: 35665477
[TBL] [Abstract][Full Text] [Related]
17. Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study.
Shionoya Y; Taniguchi T; Kasai H; Sakuma N; Imai S; Shikano K; Takayanagi S; Yahaba M; Nakada TA; Igari H; Sakao S; Suzuki T
PLoS One; 2021; 16(9):e0256977. PubMed ID: 34473766
[TBL] [Abstract][Full Text] [Related]
18. Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.
He XL; Zhou YY; Fu W; Xue YE; Liang MY; Yang BH; Ma WL; Zhou Q; Chen L; Zhang JC; Wang XR
Curr Med Sci; 2021 Dec; 41(6):1096-1104. PubMed ID: 34515914
[TBL] [Abstract][Full Text] [Related]
19. The effect of glucocorticoids on mortality in severe COVID-19 patients: Evidence from 13 studies involving 6612 cases.
Yu GQ; Jiang ZH; Yang ZB; Jiang SQ; Quan XQ
Medicine (Baltimore); 2021 Oct; 100(40):e27373. PubMed ID: 34622840
[TBL] [Abstract][Full Text] [Related]
20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
